Chaloupka et al. similarly demonstrated that radical prostatectomy without a preceding biopsy can be safe for diagnosing clinically significant prostate cancer when employing proper preoperative risk stratification, which includes mpMRI and PSMA PET imaging (Chaloupka et al. 1266). The gene discussed is FOLH1; the disease is prostate carcinoma.